What is prostate cancer, which Joe Biden has been diagnosed with? What are the treatments, and is it curable?
What is prostate cancer and why is it common among older men?
What does a Gleason score of 9 mean?
Live Events
What treatments are available for Biden's advanced prostate cancer?
Hormone Therapy (Androgen Deprivation Therapy - ADT): This is usually the first-line treatment for metastatic prostate cancer. It works by lowering testosterone, the hormone that fuels prostate cancer growth.
This is usually the for metastatic prostate cancer. It works by lowering testosterone, the hormone that fuels prostate cancer growth. Chemotherapy: Often used when hormone therapy alone isn't enough. It targets rapidly dividing cancer cells throughout the body.
Often used when hormone therapy alone isn't enough. It targets rapidly dividing cancer cells throughout the body. Radiation Therapy: While not a cure in metastatic cases, it can help reduce bone pain and target specific problem areas.
While not a cure in metastatic cases, it can help and target specific problem areas. Bone-Targeting Treatments: Drugs like bisphosphonates or radiopharmaceuticals are used to relieve pain and prevent complications caused by bone metastases.
Drugs like or are used to relieve pain and prevent complications caused by bone metastases. Immunotherapy or Targeted Therapy: In some cases, these treatments are used if the cancer has specific genetic markers or becomes resistant to standard therapies.
Can prostate cancer be cured after it spreads to the bones?
How has the public reacted to Biden's diagnosis?
What does this mean for Biden's future?
FAQs:
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
Former U.S. President Joe Biden, 82, has been diagnosed with an aggressive and advanced form of prostate cancer that has already spread to his bones, according to a medical report released Friday. The shocking diagnosis has sparked concern across the nation, especially as details confirm the cancer is metastatic and fast-growing, with a Gleason score of 9—a marker for one of the most severe cancer grades.Doctors say although the cancer has already spread, it remains hormone-sensitive, which means it can still be treated to manage symptoms and slow its progression. Here's what you need to know about prostate cancer, Biden's diagnosis, treatment options, and what it means moving forward.Prostate cancer begins in the prostate gland, a small part of the male reproductive system responsible for producing seminal fluid. It's one of the most common cancers in men, especially those over 65. The disease often progresses quietly in its early stages, with many men experiencing no symptoms until it becomes advanced.In Biden's case, doctors noted that he began experiencing, which are common warning signs in later stages. Additional tests revealed a, and biopsy results confirmed an aggressive form of the disease—already, making treatment more complex.Theis used to evaluate how aggressive prostate cancer is. The scale ranges from, with higher scores indicating. A, or, means the cancer isThis type of diagnosis is particularly serious because it significantly lowers the chances of a cure—. However, treatments can still be effective in managing symptoms and extending life.Despite the cancer's severity, Biden's medical team is hopeful because his condition is, giving doctors several viable treatment paths. These may include:Surgery, such as, is not typically used once the cancer has spread beyond the prostate gland.Once prostate cancer becomes—meaning it has spread to other parts of the body—it's generally considered. However, many menwith this diagnosis thanks toThe main goal of care shifts from curing the disease to, and. In hormone-sensitive cases like Biden's, doctors can still achieve significant progress in controlling the disease.The announcement has led to an outpouring of support from across the political spectrum.released a brief statement wishing Biden strength and a full recovery, whilepraised Biden's resilience and decades of public service.Public figures, advocacy groups, and cancer organizations have also joined in expressing solidarity, highlighting the importance of cancer awareness, screenings, and ongoing research. The diagnosis has touched many, especially as Biden remains one of the most recognizable elder statesmen in American politics.Although Joe Biden is, his health continues to be of public interest given his legacy and influence. According to his medical team, he will undergo, and specialists are confident that with the right care, he can continue to lead a meaningful and engaged life.Joe Biden has been diagnosed with, which has spread to his bones. It is classified as high-grade with aWhile it's rarely curable once it spreads to the bones,can beto manage symptoms and slow progression.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
5 hours ago
- Hindustan Times
Oncologists reveal who is more at risk of aggressive prostate cancer, explain why early detection is crucial
Back in 2014, Hollywood actor Ben Stiller was diagnosed with prostate cancer. Over the last few years, he tried to raise awareness about how early-detection helped save his life. Even veteran actor Robert De Niro is and former President of South Africa, Nelson Mandela, who died in 2013, was a prostate cancer survivor. Also read | Joe Biden diagnosed with 'aggressive' prostate cancer: All you need to know, from symptoms to cause Prostate cancer is a type of cancer that affects the prostate gland in men. In an interview with HT Lifestyle, Dr Rama Krishna, consultant in radiation oncology at Manipal Hospitals, Vijayawada, and Dr Manohar Bhadrappa, senior consultant in chief of urology, renal transplant surgeon, and uro-oncology surgeon at Manipal Hospital Sarjapur Road, explained that prostate cancer is treatable when detected early, and patients have a wider range of options available to them. Dr Krishna said that prostate cancer is one of the most common cancers in men, with 'one in six men affected during their lifetime': 'As per the Indian Council of Medical Research, around 47,000 new cases are diagnosed annually in India, accounting for 3 percent of all cancer cases. This number is expected to rise over the next 10 to 20 years due to increasing life expectancy and improved access to affordable healthcare.' Dr Bhadrappa added that approximately 15 percent of prostate cancer cases fall into the high-risk category. He said, 'These are more aggressive, with a greater chance of becoming life-threatening. While some tumours remain localised and indolent, high-risk or locally advanced cancers — defined by clinical stage T2c or higher, Gleason score of 8 or more, PSA over 20 ng/mL, or over 33 percent positive biopsy samples — require aggressive treatment.' 'Age is the most significant risk factor for prostate cancer, but increasing use of screening, heightened awareness, and factors such as family history, race, and genetics also contribute to its rising incidence. Men with a close relative diagnosed at a younger age, particularly in their 50s, are at significantly higher risk,' Dr Krishna said. He also dispelled common myths, noting that while prostate cancer is more prevalent in the elderly, 'recent data shows growing detection rates in men in their late 40s and early 50s'. 'These younger patients often present a more aggressive or advanced disease. Lack of symptoms does not mean absence of disease, as many men diagnosed with prostate cancer report only mild or vague urinary issues,' Dr Krishna said. Although there are no clearly modifiable risk factors, he stressed that regular screening is essential. 'Prostate cancer grows slowly and responds well to treatment, allowing time for effective management — provided it is detected early. Average-risk men should start screening at age 60, and high-risk individuals with family history or genetic predispositions should begin at age 50. A yearly PSA blood test is a simple way to detect risk; elevated levels should be followed by further testing as advised by a doctor,' Dr Krishna said. Dr Bhadrappa also highlighted the importance of early detection, advising PSA screening to begin at age 50 for most men, at 45 for those with a family history of prostate cancer, and at 40 if there's a family history of both breast and prostate cancers. He said, 'For high-risk patients, radical prostatectomy is the most effective treatment. This surgery involves full removal of the prostate, ensuring negative surgical margins, and extended pelvic lymph node dissection. Outcomes are best when performed by experienced urologic surgeons.' Dr Bhadrappa added that in patients with rapidly doubling PSA levels, 'cancer may spread within a year, and survival drops to 3-4 years'. He added, 'Yet, about 77 percent of high-risk patients, who undergo surgery, live beyond 10 years, proving that timely and expert intervention can significantly improve prognosis. Spot it early.' Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Economic Times
2 days ago
- Economic Times
This is why nearly 700,000 Americans lost Medicaid coverage in one month
Enrollment Declines Sharply End of Pandemic Policies Triggers Losses Administrative Issues Lead to Disenrollments Live Events Millions Disenrolled Mixed Outcomes State-Level Reductions Vary FAQs (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel New federal data reveals that nearly 700,000 Americans were removed from Medicaid in January 2025. The figures, compiled by KFF, show the ongoing impact of the federal Medicaid unwinding process. This change followed the end of COVID-19 emergency to KFF, Medicaid enrollment dropped by 669,938 between December 2024 and January 2025. This brought the total number of Medicaid enrollees to about 71.2 million. Although still above February 2020 levels, this marks a significant monthly decline in the COVID-19 public health emergency, many protections were added to Medicaid. These protections paused eligibility reviews and extended coverage for many people. When these measures ended, states resumed redetermination checks to verify if people still qualified for people lost coverage not because they no longer qualified but due to missed deadlines, paperwork errors, or out-of-date contact details. Health experts say many are falling out of the system due to communication problems and not being aware of what is needed to keep their the unwinding began in spring 2023, more than 16 million people have been removed from Medicaid. The monthly drops reflect a steady trend that began once states resumed checking eligibility. Many are still at risk of losing coverage if they do not meet the updated requirements or face administrative issues.A KFF survey in April 2024 found that among those who lost Medicaid before April 1, 2023, about 47 percent were re-enrolled. Another 28 percent found other forms of coverage. About one in four reported being uninsured after losing states have seen sharper drops in enrollment. In Montana, Tennessee, and Colorado, January 2025 figures fell below levels recorded before the pandemic began. These states have experienced faster rates of Medicaid disenrollment during the ongoing redetermination are losing coverage due to paperwork problems, communication issues, or missed deadlines, not because they no longer qualify based on income or health People who lose coverage can reapply. Some have already been re-enrolled, while others have obtained private or employer-based health plans.
Time of India
2 days ago
- Time of India
Exercising daily but sitting for long hours? New study warns your brain may still be shrinking
Live Events Smaller brain patterns linked to Alzheimer's disease Worse memory performance Faster shrinking of the hippocampus, a brain area important for memory Declines in their ability to name things and process information quickly (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel A recent study from Vanderbilt University's Memory and Alzheimer's Center has highlighted the hidden dangers of prolonged sitting on brain health . Researchers found that older adults who remain sedentary for long periods each day are at increased risk of brain shrinkage and memory decline—even if they regularly seven-year study tracked participants using wrist monitors and revealed that those who sat for around 13 hours a day had thinner brain regions tied to memory and Alzheimer's disease . The risk was even greater for individuals carrying the APOE-4 gene, which is linked to a higher chance of developing Alzheimer's. The findings suggest that regular physical activity alone may not be enough to counteract the effects of extended say prolonged sitting slows blood flow to the brain, cutting off vital oxygen and nutrients and triggering inflammation that can damage brain cells. Their findings highlight the importance of reducing sitting time and adding regular movement throughout the day to support brain takeaways of the study:People who spend more time sitting or being inactive tend to show:These effects were stronger or different depending on whether someone carried the APOE-ε4 gene, which is linked to a higher risk of Alzheimer' time, those who were more sedentary also experienced:In short: Sitting too much may be bad for your brain health, especially for memory and thinking speed, and could be worse for those with genetic risk stress that exercise alone isn't enough to undo the effects of extended inactivity. Instead, taking frequent walks, doing stretches, or simply standing up more often can make a big difference. The study shows that even if you exercise regularly, long periods of sitting can still harm your brain—making it crucial to stay active throughout the study is published in the journal Alzheimer's & Dementia
